These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 31505717

  • 41. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS, Kiriakidis S, Paleolog EM, Davies AH.
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [Abstract] [Full Text] [Related]

  • 42. Kelch-like 20 up-regulates the expression of hypoxia-inducible factor-2α through hypoxia- and von Hippel-Lindau tumor suppressor protein-independent regulatory mechanisms.
    Higashimura Y, Terai T, Yamaji R, Mitani T, Ogawa M, Harada N, Inui H, Nakano Y.
    Biochem Biophys Res Commun; 2011 Sep 23; 413(2):201-5. PubMed ID: 21888897
    [Abstract] [Full Text] [Related]

  • 43. [Hydroxysafflor yellow A up-regulates HIF-1alpha via inhibition of VHL and p53 in Eahy 926 cell line exposed to hypoxia].
    Lian ZQ, Zhao DL, Zhu HB.
    Yao Xue Xue Bao; 2008 May 23; 43(5):484-9. PubMed ID: 18717335
    [Abstract] [Full Text] [Related]

  • 44. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
    Aprelikova O, Chandramouli GV, Wood M, Vasselli JR, Riss J, Maranchie JK, Linehan WM, Barrett JC.
    J Cell Biochem; 2004 Jun 01; 92(3):491-501. PubMed ID: 15156561
    [Abstract] [Full Text] [Related]

  • 45. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
    He Z, Liu S, Guo M, Mao J, Hughson MD.
    Cancer Genet Cytogenet; 2004 Jul 15; 152(2):89-94. PubMed ID: 15262424
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. (1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism.
    Cuperlovic-Culf M, Cormier K, Touaibia M, Reyjal J, Robichaud S, Belbraouet M, Turcotte S.
    Int J Cancer; 2016 May 15; 138(10):2439-49. PubMed ID: 26620126
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC, Astuti D, Hooper L, Maxwell PH, Ratcliffe PJ, Maher ER.
    Oncogene; 2001 Aug 16; 20(36):5067-74. PubMed ID: 11526493
    [Abstract] [Full Text] [Related]

  • 50. [Effects of Bushen Wenyang Huayu Recipe on Expressions of HIF-1α, PHD2, and VHL in Endometriosis Rats with Shen Yang Deficiency Blood Stasis Syndrome].
    Jia YB, Du HL, Gao X, Bian WH, Lin XH, Ban GG, Tian QH.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct 16; 35(10):1210-7. PubMed ID: 26677673
    [Abstract] [Full Text] [Related]

  • 51. Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α.
    Fan Y, Li H, Ma X, Gao Y, Bao X, Du Q, Ma M, Liu K, Yao Y, Huang Q, Zhang Y, Zhang X.
    Oncotarget; 2016 Apr 05; 7(14):18280-94. PubMed ID: 26943772
    [Abstract] [Full Text] [Related]

  • 52. Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53.
    Cho IR, Koh SS, Min HJ, Park EH, Ratakorn S, Jhun BH, Jeong SH, Yoo YH, Youn HD, Johnston RN, Chung YH.
    Cancer Gene Ther; 2010 May 05; 17(5):365-72. PubMed ID: 20075985
    [Abstract] [Full Text] [Related]

  • 53. Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review.
    Vriend J, Reiter RJ.
    Biochim Biophys Acta; 2016 Apr 05; 1865(2):176-83. PubMed ID: 26899267
    [Abstract] [Full Text] [Related]

  • 54. Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.
    Palayoor ST, Burgos MA, Shoaibi A, Tofilon PJ, Coleman CN.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4158-64. PubMed ID: 15217953
    [Abstract] [Full Text] [Related]

  • 55. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER.
    Cancer Res; 2002 Jul 01; 62(13):3803-11. PubMed ID: 12097293
    [Abstract] [Full Text] [Related]

  • 56. Beluga whale pVHL enhances HIF-2α activity via inducing HIF-2α proteasomal degradation under hypoxia.
    Bi J, Hu B, Wang J, Liu X, Zheng J, Wang D, Xiao W.
    Oncotarget; 2017 Jun 27; 8(26):42272-42287. PubMed ID: 28178687
    [Abstract] [Full Text] [Related]

  • 57. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.
    Yu F, White SB, Zhao Q, Lee FS.
    Cancer Res; 2001 May 15; 61(10):4136-42. PubMed ID: 11358837
    [Abstract] [Full Text] [Related]

  • 58. [Expression of VHL and HIF-1alpha and its clinical significance in the lung cancer tissue].
    Peng Z, Shan C, Wang H.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Apr 15; 34(4):331-4. PubMed ID: 19411751
    [Abstract] [Full Text] [Related]

  • 59. Vhl deletion in renal epithelia causes HIF-1α-dependent, HIF-2α-independent angiogenesis and constitutive diuresis.
    Schönenberger D, Rajski M, Harlander S, Frew IJ.
    Oncotarget; 2016 Sep 20; 7(38):60971-60985. PubMed ID: 27528422
    [Abstract] [Full Text] [Related]

  • 60. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
    Beppu K, Nakamura K, Linehan WM, Rapisarda A, Thiele CJ.
    Cancer Res; 2005 Jun 01; 65(11):4775-81. PubMed ID: 15930297
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.